ARWR vs BIIB
Arrowhead Pharmaceuticals vs Biogen — AI-powered side-by-side comparison
| Metric | ARWR | BIIB |
|---|---|---|
| AI Score | 51 | 61 |
| Price | $84.64 | $202.89 |
| P/E Ratio | -39.56× | 35.73× |
| ROE | -0.0% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 1.0% | 0.7% |
| Debt / Equity | 2.24× | 0.44× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 56.3 | 48.3 |
| Beta | 1.265 | 0.158 |
| Expected Upside | +2.5% | +1.4% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ARWR Full Analysis
BIIB Full Analysis